Home > 39th Expert Committee on Drug Dependence: technical documents.

WHO Expert Committee on Drug Dependence. [WHO] (2017) 39th Expert Committee on Drug Dependence: technical documents. Geneva: World Health Organization. Thirty-ninth meeting, Geneva, 6-10 November 2017

URL: http://www.who.int/medicines/access/controlled-sub...


4. Critical reviews of psychoactive substances

4.1 AB-CHMINACA

4.2 5F-ADB

4.3 4-fluoroamphetamine (4-FA)  

4.4 AB-PINACA

4.5 Ocfentanil

4.6 Furanyl fentanyl (Fu-F)

4.7 Acryloylfentanyl (Acrylfentanyl)

4.8 Carfentanil

4.9 4-fluoroisobutyrfentanyl (4-FIBF, pFIBF)

4.10 Tetrahydrofuranylfentanyl (THF-F)

4.11 UR-144

4.12 5F-PB-22

4.13 Etizolam

5. Pre-reviews of substances  

5.1 Pregabalin*

5.2 Cannabidiol*

5.3 Tramadol*

Item Type:Evidence resource
Publication Type:Report
Drug Type:Cannabis, CNS depressants, CNS stimulants, Opioid, New psychoactive substance, Prescription/Over the counter
Intervention Type:AOD disorder, AOD disorder harm reduction
Source:WHO
Date:November 2017
Publisher:World Health Organization
Corporate Creators:WHO Expert Committee on Drug Dependence
Place of Publication:Geneva
EndNote:View
Subjects:A Drugs and alcohol use, abuse, and dependence > Drugs and alcohol effects and consequences
B Drugs and alcohol substances > Cannabis product (synthetic cannabinoids)
B Drugs and alcohol substances > Opioids (opiates)
B Drugs and alcohol substances > New (novel) psychoactive substances
E Concepts in biomedical areas > Drugs and alcohol substance by legal status > Prescription drug (medicine / medication)
L Social psychology and related concepts > Legal availability or accessibility
MM-MO Crime and law > Drugs and alcohol laws > Drug laws
VA Geographic area > International aspects

Repository Staff Only: item control page